Abstract
There are relatively few effective clinical options for preserving female fertility, particularly following aggressive chemotherapy and/or radiotherapy treatment protocols. This document reviews scientific background, current technology, clinical results, and potential future applications of ovarian tissue cryopreservation and transplantation. The technology is investigational although rapidly evolving, and the list of appropriate indications may be expanded in the future. Germany stays abreast of these rapid worldwide developments by having founded the first German network of experts for fertility preservation in patients undergoing chemotherapy and/or radiotherapy.
| Translated title of the contribution | Cryoconservation and transplantation of ovarial tissues as a therapeutic option |
|---|---|
| Original language | German |
| Journal | Gynakologische Endokrinologie |
| Volume | 4 |
| Issue number | 4 |
| Pages (from-to) | 197-204 |
| Number of pages | 8 |
| ISSN | 1610-2894 |
| DOIs | |
| Publication status | Published - 11.2006 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Cryoconservation and transplantation of ovarial tissues as a therapeutic option'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver